Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated compounds with enhanced metabolic stability and bioavailability. The combination of cyclohexyl and trifluoromethyl groups in its structure improves lipophilicity, cell permeability, and specificity toward biological targets, supporting the creation of active ingredients in drugs targeting central nervous system disorders and inflammatory conditions. The presence of the trifluoromethyl group provides resistance to oxidative degradation, making it valuable in medicinal chemistry. Also employed in agrochemicals for the production of herbicides and pesticides where fluorine substitution increases efficacy and environmental persistence. Additionally, applied in the synthesis of polymers requiring resistance to chemicals and high temperatures.